Alnylam Pharmaceuticals | Текущие Обязательства



Current Liabilities Изменить Дата
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sanofi 29.16B 865M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Takeda JPY 2.51T 408.56B 2025-03
Tectonic Therapeutic USD 11.61M 5.71M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Xencor USD 88.44M 1M 2025-03



Alnylam Pharmaceuticals Текущие Обязательства - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.